These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 12606138

  • 1. Translocation (X;20)(q13.1;q13.3) as a primary chromosomal finding in two patients with myelocytic disorders.
    Gray BA, Cornfield D, Bent-Williams A, Zori RT.
    Cancer Genet Cytogenet; 2003 Mar; 141(2):169-74. PubMed ID: 12606138
    [Abstract] [Full Text] [Related]

  • 2. Translocation (X;20)(q13;q13.3): a nonrandom abnormality in four patients with myeloid disorders.
    Reddy KS, Richkind K, Ross M, Seirra R.
    Cancer Genet Cytogenet; 2005 Feb; 157(1):70-3. PubMed ID: 15676151
    [Abstract] [Full Text] [Related]

  • 3. Cryptic translocations involving chromosome 20 in polycythemia vera.
    Busson M, Romana S, Nguyen Khac F, Bernard O, Berger R.
    Ann Genet; 2004 Feb; 47(4):365-71. PubMed ID: 15581834
    [Abstract] [Full Text] [Related]

  • 4. Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia.
    Bram S, Swolin B, Rödjer S, Stockelberg D, Ogärd I, Bäck H.
    Cancer Genet Cytogenet; 2003 Apr 15; 142(2):107-14. PubMed ID: 12699885
    [Abstract] [Full Text] [Related]

  • 5. Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocations.
    Manola KN, Stavropoulou C, Georgakakos VN, Zoi K, Fisfis M, Evmorfiadis I, Zoi C, Pantelias GE, Stefanoudaki K, Sambani C.
    Leuk Res; 2007 Jul 15; 31(7):1009-14. PubMed ID: 17204324
    [Abstract] [Full Text] [Related]

  • 6. Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.
    O'Reilly J, Crawford J, Uzaraga J, Cannell P.
    Cancer Genet Cytogenet; 2005 Apr 01; 158(1):81-3. PubMed ID: 15771910
    [Abstract] [Full Text] [Related]

  • 7. A new nonrandom unbalanced t(17;20) in myeloid malignancies.
    Patsouris C, Michael PM, Campbell LJ.
    Cancer Genet Cytogenet; 2002 Oct 01; 138(1):32-7. PubMed ID: 12419582
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of the del(20q) chromosome in hematologic disorders.
    Aatola M, Armstrong E, Teerenhovi L, Borgström GH.
    Cancer Genet Cytogenet; 1992 Aug 01; 62(1):75-80. PubMed ID: 1521239
    [Abstract] [Full Text] [Related]

  • 9. A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndrome.
    Bernasconi P, Cavigliano PM, Genini E, Castagnola C, Malcovati L, Calatroni S, Caresana M, Boni M, Alessandrino EP, Astori C, Corso A, Bernasconi C.
    Cancer Genet Cytogenet; 1998 Sep 01; 105(2):182-6. PubMed ID: 9723039
    [Abstract] [Full Text] [Related]

  • 10. Translocation t(3;21)(q26;q22) in acute myeloblastic leukemia secondary to polycythemia vera.
    Dastugue N, Pris J, Colombies P.
    Cancer Genet Cytogenet; 1990 Feb 01; 44(2):275-6. PubMed ID: 2297687
    [Abstract] [Full Text] [Related]

  • 11. A novel t(16;20)(q22;p13) in polycythemia vera.
    Daibata M, Taguchi T, Taguchi H.
    Cancer Genet Cytogenet; 2002 Aug 01; 137(1):29-32. PubMed ID: 12377410
    [Abstract] [Full Text] [Related]

  • 12. t(8;21) prior to acute leukemia.
    Berger R, Hillion J, Janvier D, Chen Z, Bussel A.
    Cancer Genet Cytogenet; 1993 Oct 15; 70(2):125-6. PubMed ID: 8242592
    [Abstract] [Full Text] [Related]

  • 13. Different mechanisms lead to a karyotypically identical t(20;21) in myelodysplastic syndrome and in acute myelocytic leukemia.
    Matteucci C, La Starza R, Crescenzi B, Romoli S, Santoro A, Magrin S, Lauria F, Coco FL, Martelli MF, Mecucci C.
    Cancer Genet Cytogenet; 2003 Jan 01; 140(1):13-7. PubMed ID: 12550752
    [Abstract] [Full Text] [Related]

  • 14. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
    Xu W, Li JY, Liu Q, Zhu Y, Pan JL, Qiu HR, Xue YQ.
    Int J Lab Hematol; 2010 Feb 01; 32(1 Pt 1):e86-95. PubMed ID: 20089000
    [Abstract] [Full Text] [Related]

  • 15. Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders.
    Bram S, Rödjer S, Swolin B.
    Cancer Genet Cytogenet; 2004 Nov 01; 155(1):74-8. PubMed ID: 15527906
    [Abstract] [Full Text] [Related]

  • 16. Geographic heterogeneity of chromosome aberrations in hematologic disorders.
    Mitelman F.
    Cancer Genet Cytogenet; 1986 Feb 15; 20(3-4):203-8. PubMed ID: 3455865
    [Abstract] [Full Text] [Related]

  • 17. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O, Hofmann WK, Baldus CD, Thiel G, Serbent V, Schümann E, Thiel E, Blau IW.
    Exp Hematol; 2007 Feb 15; 35(2):221-9. PubMed ID: 17258071
    [Abstract] [Full Text] [Related]

  • 18. Derivative (y)t(Y;1)(q12;q12),+9 in a patient with polycythemia vera during transition into myelodysplasia.
    Raymakers R, Stellink F, Geurts van Kessel A.
    Cancer Genet Cytogenet; 1996 May 15; 88(1):83-5. PubMed ID: 8630987
    [Abstract] [Full Text] [Related]

  • 19. Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies are strongly associated with neoplasms of the myeloid lineages.
    Johansson B, Brøndum-Nielsen K, Billström R, Schiødt I, Mitelman F.
    Cancer Genet Cytogenet; 1997 Dec 15; 99(2):97-101. PubMed ID: 9398862
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.